Vergara SA, Valdez OR, Berman PN, Ezquerra OA, Figueroa RG, Salero MD, Sánchez RA

Language: Spanish
References: 22
Page: 208-213
PDF size: 174.59 Kb.

ABSTRACT

Introduction: Information regarding severity of uremic pruritus, impact on sleep quality in patients with end stage renal disease (ESRD) in renal replacement therapy (RRT) is scarce in Mexico. Objective: To correlate clinical and biochemical features, body mass index (BMI), sleep quality impairment with severity of uremic pruritus in patients with ESRD in RRT. Material and methods: Cross sectional study with patients of "Hospital General de México" from August through September 2018. Clinical, biochemical and sleep quality variables were collected. Characteristics of pruritus four weeks before assessment was obtained. A descriptive analysis and multivariate logistic regression for severe pruritus [visual analogue scale (VAS) of > 6 points] were analyzed. Results: Data from 99 patients was included. 60.6% male, age 44.9 ± 4.2 years. Patients with severe pruritus were older (42.4 vs 49.7 years p = 0.021), had higher BMI (23.8 vs 25.9 kg/m², p = 0.019). Other associations identified were BMI ≥ 24 kg/m² [OR = 3.37 (95% CI 1.008-11.29, p = 0.049)], disseminated pruritus [OR = 17.2 (95% CI 1.039-286.6, p = 0.047)]; awakenings OR = 10.9 (95% CI 2.21-53.87, p = 0.003). No association was observed for biochemical variables or TRR modality. Conclusions: Severe uremic pruritus was associated with higher BMI, older age, disseminated affection and awakenings.

REFERENCES

1. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395 (10225): 709-733.

2. Agudelo-Botero M, González-Robledo MC, Reyes-Morales H, Giraldo-Rodríguez L, Rojas-Russell M, Mino-León D et al. Health care trajectories and barriers to treatment for patients with end-stage renal disease without health insurance in Mexico: a mixed methods approach. Int J Equity Health. 2020; 19 (1): 90

3. Alegre-Díaz J, Herrington W, López-Cervantes M, Gnatiuc L, Ramirez R, Hill M et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med. 2016; 375 (20): 1961-1971.

4. Torazza MC, Salomone M, Albanesi T, Deabate MC, Zina A, Triolo G. Uremic pruritus. Minerva Urol Nefrol. 1997; 49 (3): 125-132.

5. Valdez-Ortiz R, Vergara-Suárez A. Perspectiva dermatológica del prurito urémico: Un padecimiento común pero poco reconocido. Dermatol Rev Mex. 2017; 61 (6): 537-540.

6. Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant. 2006; 21 (3): 749-755.

7. Cho YL, Liu HN, Huang TP, Tarng DC. Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol. 1997; 36 (4): 538-543.

8. Kossuth-Cabrejos S, Gavino-Gutiérrez AM, Silva-Caso W. Factors associated with the severity of pruritus in patients with terminal chronic kidney disease undergoing hemodialysis in Lima, Peru. Dermatol Reports. 2020; 12 (1): 8310.

9. Shirazian S, Aina O, Park Y, Chowdhury N, Leger K, Hou L et al. Chronic kidney disease-associated pruritus: Impact on quality of life and current management challenges. Int J Nephrol Renovasc Dis. 2017; 10: 11-26.

10. Rhee EP, Guallar E, Hwang S, Kim N, Tonelli M, Moe SM et al. Prevalence and persistence of uremic symptoms in incident dialysis patients. Kidney 360. 2020; 1 (2): 86-92.

11. Maya GN, Valdez OR, Mayoral RH. Chronic kidney disease associated pruritus impact on dermatological quality of life of patients with chronic renal replacement therapy in hemodialysis from the General Hospital of Mexico. J Am Acad Dermatol. 2016; 74 (5): AB168.

12. Kataoka K. Indices of obesity derived from body weight and height. Nihon Rinsho. 1995; 53 (Suppl. 3): 147-153.

13. Hampers CL, Katz AI, Wilson RE, Merrill JP. Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med. 1968; 279 (13): 695-697.

14. Ko MJ, Wu HY, Chen HY, Chiu YL, Hsu SP, Pai MF et al. Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort study. PLoS One. 2013; 8 (8): e71404.

15. Wu HY, Peng Y Sen, Chen HY, Tsai WC, Yang JY, Hsu SP et al. A comparison of uremic pruritus in patients receiving peritoneal dialysis and hemodialysis. Medicine (Baltimore). 2016; 95 (9): e2935.

16. Min J-W, Kim S-H, Kim YO, Jin DC, Song HC, Choi EJ et al. Comparison of uremic pruritus between patients undergoing hemodialysis and peritoneal dialysis. Kidney Res Clin Pract. 2016; 35 (2): 107-113.

17. Ko MJ, Peng Y Sen, Chen HY, Hsu SP, Pai MF, Yang JY et al. Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis. J Am Acad Dermatol. 2014; 71 (6): 1151-1159.e1.

18. Decleves AE, Sharma K. Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis. Curr Opin Nephrol Hypertens. 2015; 24 (1): 28-36.

19. Markova I, Miklankova D, Hüttl M, Kacer P, Skibova J, Kucera J et al. The effect of lipotoxicity on renal dysfunction in a nonobese rat model of metabolic syndrome: a urinary proteomic approach. J Diabetes Res. 2019; 2019.

20. Satti MZ, Arshad D, Javed H, Shahroz A, Tahir Z, Ahmed MMH et al. Uremic pruritus: prevalence and impact on quality of life and depressive symptoms in hemodialysis patients. Cureus. 2019; 11 (7): e5178.

21. Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML et al. Pruritus in haemodialysis patients: international results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2006; 21 (12): 3495-3505.

22. Mathur VS, Lindberg J, Germain M, Block G, Tumlin J, Smith M et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010; 5 (8): 1410-1419.